Loading clinical trials...
Loading clinical trials...
The Quantification of Ingestive Behavior
The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.
This study aims to explore whether short-term measures of eating behavior can be related to later, longer-term weight loss. In a double-blind, randomized fashion, participants will be asked to take study medication for three weeks: one week of phentermine and two weeks of placebo. At the end of the first and third weeks, participants will be asked to participate in a range of eating behavior studies. Following this three-week, double-blind phase, participants will be offered 6 months of open treatment for weight loss.
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
No
The New York State Psychiatric Institute at Columbia University Medical Center
New York, New York, United States
Start Date
July 1, 2012
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
July 31, 2017
13
ACTUAL participants
Phentermine
DRUG
placebo
DRUG
Lead Sponsor
New York State Psychiatric Institute
Collaborators
NCT07472881
NCT01143454
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions